Growth Metrics

NovoCure (NVCR) Accumulated Expenses (2016 - 2018)

Historic Accumulated Expenses for NovoCure (NVCR) over the last 5 years, with Q4 2018 value amounting to $16.7 million.

  • NovoCure's Accumulated Expenses rose 2585.26% to $16.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $16.7 million, marking a year-over-year increase of 2585.26%. This contributed to the annual value of $16.7 million for FY2018, which is 2585.26% up from last year.
  • Per NovoCure's latest filing, its Accumulated Expenses stood at $16.7 million for Q4 2018, which was up 2585.26% from $13.3 million recorded in Q4 2017.
  • Over the past 5 years, NovoCure's Accumulated Expenses peaked at $16.7 million during Q4 2018, and registered a low of $5.8 million during Q4 2014.
  • In the last 5 years, NovoCure's Accumulated Expenses had a median value of $8.3 million in 2015 and averaged $10.3 million.
  • Per our database at Business Quant, NovoCure's Accumulated Expenses tumbled by 868.25% in 2016 and then surged by 7614.37% in 2017.
  • NovoCure's Accumulated Expenses (Quarter) stood at $5.8 million in 2014, then skyrocketed by 41.26% to $8.3 million in 2015, then fell by 8.68% to $7.5 million in 2016, then surged by 76.14% to $13.3 million in 2017, then increased by 25.85% to $16.7 million in 2018.
  • Its last three reported values are $16.7 million in Q4 2018, $13.3 million for Q4 2017, and $7.5 million during Q4 2016.